FUSMobile, INC

FUSMobile, INC manufactures the Neurolyser XR, a non-invasive therapeutic ultrasound system designed to treat chronic low back pain associated with facet arthritis and vertebral facet joint dysfunction. The Neurolyser XR platform delivers fluoroscopy-guided, focused ultrasound ablative therapy without surgical intervention. The company positions its technology as providing pain relief outcomes comparable to or exceeding invasive standard-of-care procedures while reducing procedure time, complexity, and adverse events. The system is designed for use in clinical settings to address chronic pain management with emphasis on faster patient recovery, reduced healthcare costs, and improved overall patient experience. Target markets include pain management clinics, orthopedic practices, and healthcare systems seeking non-invasive alternatives to surgical interventions for facet-mediated low back pain.